Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
cholesterol
Biotech
FDA hands Verve list of demands for lifting gene editing hold
Officials want additional data to allay concerns that patients could pass on the edited genes to their children before they lift the clinical hold.
Nick Paul Taylor
Dec 5, 2022 9:20am
Verily's Onduo slashes blood sugar in Type 2 diabetes patients
Nov 7, 2022 10:30am
Merck looks to cardiovascular pipeline for $10B-plus peak sales
Apr 5, 2022 5:24pm
ACC: Ionis-AstraZeneca drug reduces troublesome cholesterol
Apr 4, 2022 10:08am
Phase 3 hits tee Innovent up to rival Amgen and Sanofi in PCSK9
Feb 17, 2022 9:40am
AstraZeneca punts midphase cardiovascular prospect to startup
Feb 3, 2022 7:05am